BioNotebook: Bubble speculation, stock offerings, IPOs and venture capital funding
This article was originally published in Scrip
Executive Summary
Are we in a bubble and is it about to burst? You could say that's the question of the moment, but really it's the question that everyone in and around the biotechnology industry has been asking for the past year due to skyrocketing public biotech company values and the soaring initial public offering market.